Edges in Network
| Network | GSE12093_top500tf - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | E2F5 |
| Upstream (Parents) |
|---|
| (<<) PKNOX2 → E2F5 |
| (<<) ONECUT1 → E2F5 |
| (<<) ZNF45 → E2F5 |
| (<<) YBX1 → E2F5 |
| (<<) POU4F2 → E2F5 |
| (<<) MYC → E2F5 |
| (<<) HSF1 → E2F5 |
| (<<) SOX5 → E2F5 |
| (<<) AFF1 → E2F5 |
| (<<) NFYB → E2F5 |
| (<<) HHEX → E2F5 |
| (<<) TFEB → E2F5 |
| (<<) ZNF131 → E2F5 |
| (<<) ZNF24 → E2F5 |
| Downstream (Children) |
|---|
| E2F5 → ASCL1 (>>) |
| E2F5 → ZIC1 (>>) |
| E2F5 → ZNF165 (>>) |
| E2F5 → ZNF157 (>>) |
| E2F5 → NPAS2 (>>) |
| E2F5 → MLLT10 (>>) |
| E2F5 → CITED2 (>>) |
| E2F5 → TFAP2C (>>) |
| E2F5 → NFATC4 (>>) |
| E2F5 → NFIX (>>) |
| E2F5 → MYF6 (>>) |
| E2F5 → SOX9 (>>) |
| E2F5 → EN2 (>>) |
| E2F5 → PEG3 (>>) |
| E2F5 → SMAD3 (>>) |
| E2F5 → FOSL2 (>>) |
| E2F5 → RXRA (>>) |
| E2F5 → TAF12 (>>) |
| E2F5 → TAL1 (>>) |
| E2F5 → SOX21 (>>) |
| E2F5 → HMX1 (>>) |
| E2F5 → PAX7 (>>) |
